ArticleOncotarget2012

Too much AKT turns PAX3-FKHR dead: a prospect of novel therapeutic strategy for alveolar rhabdomyosarcoma.

Mathivanan Jothi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.